Xinglian Capital
Xinglian Capital appears in 2 AI deals tracked on Lounge in 2026.
Investing activity
Xinglian Capital appears in 2 AI deals tracked by the Lounge deals desk, rounds totalling $65M, and led 1 of them. The rounds are mostly Seed, with a median round size of $50M. The most recent are Apex Intelligence (Angel (seed), $50M, Sep 2026) and Aifei Intelligent Pharma (Angel (seed), $14.9M (CNY 100.0M), Sep 2026).
Xinglian Capital most often invests alongside Zhongguancun Science City, IDG Capital, XtalPi and Shanghai Future Industry Fund, and the companies it backs on Lounge are mostly in AI.
Deals
Frequently asked questions about Xinglian Capital
What AI companies has Xinglian Capital invested in?
Xinglian Capital's AI investments include Apex Intelligence and Aifei Intelligent Pharma. The 2 rounds on Lounge are listed on this page with amounts, dates and co-investors.
What stage does Xinglian Capital invest at?
In the rounds tracked on Lounge, Xinglian Capital has invested at Seed, with a median round of $50M. Xinglian Capital led 1 of those rounds.
Who does Xinglian Capital co-invest with?
Xinglian Capital's most frequent co-investors on Lounge are Zhongguancun Science City (1 deal), IDG Capital (1 deal), XtalPi (1 deal), Shanghai Future Industry Fund (1 deal) and SCGC Group (1 deal).
How can founders reach Xinglian Capital?
Founders on Lounge can see Xinglian Capital's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Xinglian Capital to their Investor Pipeline to track the conversation.